CN114392327A - 一种用于尿毒症和降低肌酐的组合物及其用途与制备方法 - Google Patents
一种用于尿毒症和降低肌酐的组合物及其用途与制备方法 Download PDFInfo
- Publication number
- CN114392327A CN114392327A CN202210057119.7A CN202210057119A CN114392327A CN 114392327 A CN114392327 A CN 114392327A CN 202210057119 A CN202210057119 A CN 202210057119A CN 114392327 A CN114392327 A CN 114392327A
- Authority
- CN
- China
- Prior art keywords
- parts
- root
- charred
- composition
- creatinine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 title claims abstract description 76
- 239000000203 mixture Substances 0.000 title claims abstract description 56
- 229940109239 creatinine Drugs 0.000 title claims abstract description 38
- 208000037157 Azotemia Diseases 0.000 title claims abstract description 34
- 208000009852 uremia Diseases 0.000 title claims abstract description 34
- 230000009467 reduction Effects 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title abstract description 17
- 239000003814 drug Substances 0.000 claims abstract description 44
- 244000124853 Perilla frutescens Species 0.000 claims abstract description 39
- 235000004347 Perilla Nutrition 0.000 claims abstract description 35
- 239000002994 raw material Substances 0.000 claims abstract description 34
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 19
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 19
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 19
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 19
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 19
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 19
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 19
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 19
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 19
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 19
- 240000000982 Malva neglecta Species 0.000 claims abstract description 19
- 235000000060 Malva neglecta Nutrition 0.000 claims abstract description 19
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims abstract description 19
- 240000001398 Typha domingensis Species 0.000 claims abstract description 19
- 241000213006 Angelica dahurica Species 0.000 claims abstract description 18
- 241001598107 Imperata Species 0.000 claims abstract description 18
- 235000014676 Phragmites communis Nutrition 0.000 claims abstract description 18
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract description 18
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 18
- 235000008282 Sanguisorba officinalis Nutrition 0.000 claims abstract description 18
- 238000001035 drying Methods 0.000 claims abstract description 18
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 18
- 235000008291 Poterium sanguisorba Nutrition 0.000 claims abstract description 17
- 241001180876 Saposhnikovia Species 0.000 claims abstract description 17
- 241000951473 Schizonepeta Species 0.000 claims abstract description 17
- 244000025254 Cannabis sativa Species 0.000 claims abstract description 15
- 244000247747 Coptis groenlandica Species 0.000 claims abstract description 14
- 235000002991 Coptis groenlandica Nutrition 0.000 claims abstract description 14
- 229940079593 drug Drugs 0.000 claims abstract description 13
- 239000003610 charcoal Substances 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 238000004140 cleaning Methods 0.000 claims abstract description 10
- 238000000227 grinding Methods 0.000 claims abstract description 8
- 238000005303 weighing Methods 0.000 claims abstract description 8
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 5
- 241000123069 Ocyurus chrysurus Species 0.000 claims abstract 5
- 240000004064 Poterium sanguisorba Species 0.000 claims abstract 5
- 238000000034 method Methods 0.000 claims description 7
- 241000037740 Coptis chinensis Species 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 240000007171 Imperata cylindrica Species 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000007858 starting material Substances 0.000 claims 1
- 230000027939 micturition Effects 0.000 abstract description 6
- 239000003053 toxin Substances 0.000 abstract description 4
- 231100000765 toxin Toxicity 0.000 abstract description 4
- 210000001835 viscera Anatomy 0.000 abstract description 4
- 239000008280 blood Substances 0.000 description 19
- 210000004369 blood Anatomy 0.000 description 19
- 230000000694 effects Effects 0.000 description 18
- 241001092040 Crataegus Species 0.000 description 14
- 244000173853 Sanguisorba officinalis Species 0.000 description 14
- 241001149655 Rubia tinctorum Species 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 11
- 208000032843 Hemorrhage Diseases 0.000 description 8
- RGCKGOZRHPZPFP-UHFFFAOYSA-N alizarin Chemical compound C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 230000000740 bleeding effect Effects 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 6
- 208000001647 Renal Insufficiency Diseases 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 201000006370 kidney failure Diseases 0.000 description 6
- 208000011580 syndromic disease Diseases 0.000 description 6
- 235000019640 taste Nutrition 0.000 description 6
- 208000004998 Abdominal Pain Diseases 0.000 description 5
- 241000207923 Lamiaceae Species 0.000 description 5
- 206010042674 Swelling Diseases 0.000 description 5
- 206010047700 Vomiting Diseases 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 239000012535 impurity Substances 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 235000004348 Perilla frutescens Nutrition 0.000 description 4
- 208000001431 Psychomotor Agitation Diseases 0.000 description 4
- 206010038743 Restlessness Diseases 0.000 description 4
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N Tanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 208000020832 chronic kidney disease Diseases 0.000 description 4
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 230000003907 kidney function Effects 0.000 description 4
- 230000008673 vomiting Effects 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 3
- 208000034507 Haematemesis Diseases 0.000 description 3
- 206010027514 Metrorrhagia Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 208000035861 hematochezia Diseases 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010000234 Abortion spontaneous Diseases 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 241000209504 Poaceae Species 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 240000009235 Rubia cordifolia Species 0.000 description 2
- 229930183118 Tanshinone Natural products 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 238000007605 air drying Methods 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 208000035850 clinical syndrome Diseases 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 230000002439 hemostatic effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 208000017169 kidney disease Diseases 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 208000015994 miscarriage Diseases 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- LVHLZMUFIYAEQB-UHFFFAOYSA-N perilla ketone Chemical compound CC(C)CCC(=O)C=1C=COC=1 LVHLZMUFIYAEQB-UHFFFAOYSA-N 0.000 description 2
- RUMOYJJNUMEFDD-UHFFFAOYSA-N perillyl aldehyde Chemical compound CC(=C)C1CCC(C=O)=CC1 RUMOYJJNUMEFDD-UHFFFAOYSA-N 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 208000000995 spontaneous abortion Diseases 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 2
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- GVKKJJOMQCNPGB-JTQLQIEISA-N Cryptotanshinone Chemical compound O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1[C@@H](C)CO2 GVKKJJOMQCNPGB-JTQLQIEISA-N 0.000 description 1
- GVKKJJOMQCNPGB-UHFFFAOYSA-N Cryptotanshinone Natural products O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1C(C)CO2 GVKKJJOMQCNPGB-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 101000937129 Drosophila melanogaster Cadherin-related tumor suppressor Proteins 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- UGNZSMZSJYOGNX-UHFFFAOYSA-N Isoviocristine Natural products O=C1C=C(C)C(=O)C2=CC3=CC(OC)=CC(O)=C3C(O)=C21 UGNZSMZSJYOGNX-UHFFFAOYSA-N 0.000 description 1
- 241000219071 Malvaceae Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 244000273256 Phragmites communis Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 241001107098 Rubiaceae Species 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 244000182022 Salvia sclarea Species 0.000 description 1
- 235000002911 Salvia sclarea Nutrition 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 235000004224 Typha angustifolia Nutrition 0.000 description 1
- 241001518821 Typha orientalis Species 0.000 description 1
- 241000233945 Typhaceae Species 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- -1 alizarin Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- YMBFCQPIMVLNIU-KKUMJFAQSA-N alpha-Bergamotene Natural products C1[C@@H]2[C@](CCC=C(C)C)(C)[C@H]1CC=C2C YMBFCQPIMVLNIU-KKUMJFAQSA-N 0.000 description 1
- GYJHTGZQPKPEOT-SNVBAGLBSA-N alpha-Linalool Natural products O[C@](C=C)(CCCC(=C)C)C GYJHTGZQPKPEOT-SNVBAGLBSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- WLXGUTUUWXVZNM-UHFFFAOYSA-N anthraglycoside A Natural products C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1OC1OC(CO)C(O)C(O)C1O WLXGUTUUWXVZNM-UHFFFAOYSA-N 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- DGZBGCMPRYFWFF-UHFFFAOYSA-N beta-trans-Bergamoten Natural products C1C2C(CCC=C(C)C)(C)C1CCC2=C DGZBGCMPRYFWFF-UHFFFAOYSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 210000000613 ear canal Anatomy 0.000 description 1
- JYYFMIOPGOFNPK-AGRJPVHOSA-N ethyl linolenate Chemical compound CCOC(=O)CCCCCCC\C=C/C\C=C/C\C=C/CC JYYFMIOPGOFNPK-AGRJPVHOSA-N 0.000 description 1
- 229940090028 ethyl linolenate Drugs 0.000 description 1
- JYYFMIOPGOFNPK-UHFFFAOYSA-N ethyl linolenate Natural products CCOC(=O)CCCCCCCC=CCC=CCC=CCC JYYFMIOPGOFNPK-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 150000004338 hydroxy anthraquinones Chemical class 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 229930195208 isotanshinone Natural products 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005360 mashing Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 210000005084 renal tissue Anatomy 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 235000015359 salad burnet Nutrition 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 239000001691 salvia sclarea Substances 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229930189533 tanshinol Natural products 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- YMBFCQPIMVLNIU-UHFFFAOYSA-N trans-alpha-bergamotene Natural products C1C2C(CCC=C(C)C)(C)C1CC=C2C YMBFCQPIMVLNIU-UHFFFAOYSA-N 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- YMBFCQPIMVLNIU-GRKKQISMSA-N α-bergamotene Chemical compound C1[C@H]2C(CCC=C(C)C)(C)[C@@H]1CC=C2C YMBFCQPIMVLNIU-GRKKQISMSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/538—Schizonepeta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/739—Sanguisorba (burnet)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8998—Hordeum (barley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用于尿毒症和降低肌酐的组合物及其用途与制备方法,该组合物的原料优选地,按重量计包含:荆芥穗炭10g、防风6g、白芷6g、苏叶10g、苏梗10g、黄连2g、丹参10g、茜草10g、地榆10g、白茅根30g、芦根30g、锦葵1g、蒲黄6g,以及焦麦芽、焦山楂、焦神曲各10g组成的焦三仙。本发明还提供了该组合物的用途,该组合物用于制备内服的药剂。本发明也提供了该药剂的制备方法,该方法为:按比例称量各药物,并将可清洗的原料洗净干燥,然后将全部原料研磨破碎,再加水煎煮,得到汤剂。本发明提供的组合物用于尿毒症,能够有效调节人体五脏六腑,排毒利尿,并可以降低肌酐和恢复正常肌酐值。
Description
技术领域
本发明涉及一种药物组合物及其用途与制备方法,具体地,涉及一种用于尿毒症和降低肌酐的组合物及其用途与制备方法。
背景技术
慢性肾衰竭是指各种肾脏病导致肾脏功能渐进性不可逆性减退,直至功能丧失所出现的一系列症状和代谢紊乱所组成的临床综合征,简称慢性肾衰。慢性肾衰的终末期即为人们常说的尿毒症。尿毒症不是一个独立的疾病,而是各种晚期的肾脏病共有的临床综合征,是慢性肾功能衰竭进入终末阶段时出现的一系列临床表现所组成的综合征。
尿毒症是肾脏组织几乎纤维化,导致肾脏功能丧失的结果。现有的医疗技术治疗尿毒症只有通过血液透析、腹膜透析和换肾来治疗,透析给病人带来了极大的不便和痛苦,换肾更是还要承受高额的费用,还会出现排异现象。
每年因为肾衰死亡患者十几万人,每年新增肾衰病患者过百万,是世界几亿人民难题。目前,市场上还没有中草药天然植物等成分的产品可以降低肌酐与恢复肾衰,乃至恢复正常。
发明内容
本发明的目的是提供一种药物组合物及其用途与制备方法,该组合物能够解决现有问题,用于尿毒症,可以降低肌酐和恢复正常肌酐值。
为了达到上述目的,本发明提供了一种用于尿毒症和降低肌酐的组合物,其中,该组合物的原料包含:荆芥穗炭、防风、白芷、苏叶、苏梗、黄连、丹参、茜草、地榆、白茅根、芦根、锦葵、蒲黄、焦三仙。
上述的用于尿毒症和降低肌酐的组合物,其中,所述的组合物的原料中,焦三仙由焦麦芽、焦山楂、焦神曲按重量比1:1:1组成。
上述的用于尿毒症和降低肌酐的组合物,其中,所述的组合物的原料按重量份数计包含:荆芥穗炭8~15份、防风5~7份、白芷5~7份、苏叶8~12份、苏梗8~14份、黄连1~3份、丹参8~15份、茜草8~15份、地榆8~15份、白茅根25~35份、芦根25~35份、锦葵0.5~1.5份、蒲黄5~7份,以及焦麦芽、焦山楂、焦神曲各8~12份组成的焦三仙。
上述的用于尿毒症和降低肌酐的组合物,其中,所述的原料按重量份数计包含:荆芥穗炭10份、防风6份、白芷6份、苏叶10份、苏梗10份、黄连2份、丹参10份、茜草10份、地榆10份、白茅根30份、芦根30份、锦葵1份、蒲黄6份,以及焦麦芽、焦山楂、焦神曲各10份组成的焦三仙。
上述的用于尿毒症和降低肌酐的组合物,其中,所述的原料按重量计包含:荆芥穗炭10g、防风6g、白芷6g、苏叶10g、苏梗10g、黄连2g、丹参10g、茜草10g、地榆10g、白茅根30g、芦根30g、锦葵1g、蒲黄6g,以及焦麦芽、焦山楂、焦神曲各10g组成的焦三仙。
本发明还提供了上述的用于尿毒症和降低肌酐的组合物的用途,其中,所述的组合物用于制备内服的药剂。
本发明还提供了上述的药剂的制备方法,其中,所述的方法为:按比例称量各药物,并将可清洗的原料洗净干燥,然后将全部原料研磨破碎,再加水煎煮,得到汤剂。
上述的药剂的制备方法,其中,所述的汤剂,每天口服一剂。
本发明提供的用于尿毒症和降低肌酐的组合物及其用途与制备方法具有以下优点:
本发明利用生物制药等科技与高度提纯提取手段,经过中科院中医科学院配合验证,突破了肾衰病康复治疗的现有技术,能够有效调节人体五脏六腑,排毒利尿,降低人体肌酐,恢复人体肌酐正常。该组合物用于尿毒症,可以达到恢复肾衰竭,乃至恢复肾脏功能的效果。
具体实施方式
以下对本发明的具体实施方式作进一步地说明。
本发明提供的用于尿毒症和降低肌酐的组合物,该组合物的原料包含:荆芥穗炭、防风、白芷、苏叶、苏梗、黄连、丹参、茜草、地榆、白茅根、芦根、锦葵、蒲黄、焦三仙。
该组合物原料中的焦三仙由焦麦芽、焦山楂、焦神曲按重量比1:1:1组成。
其中,荆芥穗炭为采自唇形科植物荆芥的荆芥穗的炮制加工品。气芳香,味微涩而辛凉。归肺、肝经。穗绿时采摘,除去杂质,晒干。取荆芥穗段,依清炒法(不加辅料的炒法称为清炒法)炒至表面黑褐色,内部焦黄色,喷淋清水少许,熄灭火星,取出,晾干。具有收涩止血的功效。用于便血,崩漏,产后血晕。
防风为伞形科植物防风的根。多年生草本植物,其喜凉爽气候,耐寒,耐干旱,主产于河北、黑龙江、四川、内蒙古等地。防风的根可生用。味辛、甘,性微温。归膀胱、肺、脾、肝经。有祛风解表,胜湿止痛,止痉的功效。用于外感表证,风疹瘙痒,风湿痹痛,破伤风正,脾虚湿盛。
白芷为多年高大草本植物,白芷内含有丰富的蛋白质脂肪,碳水化合物,微量元素,药用价值高,白芷根入药,能祛风散湿、排脓、生肌、止痛,主治风寒感冒,前额头痛,鼻窦炎、牙痛、痔漏、便血、白带、痈疽肿毒、烧伤等症。
苏叶即紫苏叶,为唇形科植物紫苏的干燥叶(或带嫩枝)。夏季枝叶茂盛时采收,除去杂质,晒干。气清香,味微辛。归肺、脾经。含挥发油:紫苏醛、柠檬烯、β丁香烯、α香柑油烯、芳樟醇等。具有散寒解表,行气化痰,安胎,解鱼蟹毒的功效。主治风寒表证,咳嗽痰多,胸脘胀满,恶心呕吐,腹痛吐泻,胎气不和,妊娠恶阻,食鱼蟹中毒。
苏梗即紫苏梗,为唇形科紫苏属植物紫苏或野紫苏的茎。9-11月采收,割取地上部分,除去小枝、叶片、果实,晒干。紫苏地上部分含紫苏酮,异白苏烯酮,白苏烯酮,紫苏为然,亚麻酸乙酯,亚麻酸及β-谷甾醇。具有理气宽中,安胎,和血的功效。主治脾胃气滞,脘腹痞满,胎气不和,水肿脚气,咯血吐衄。
黄连为毛茛科植物黄连、三角叶黄连或云连的干燥根茎。分布于四川、贵州、湖南、湖北、陕西南部。黄连片除去杂质,润透后切薄片,晾干或用时捣碎。味苦,性寒。归心、脾、胃、肝、胆、大肠经。有清热燥湿,泻火解毒之功效。主治湿热痞满,呕吐吞酸,泻痢,黄疸,高热神昏,心火亢盛,心烦不寐,心悸不宁,血热吐衄,目赤,牙痛,消渴,痈肿疗疮;外治湿疹,湿疮,耳道流脓。
丹参为唇形科植物丹参的干燥根和根茎。味苦,微寒。归心、肝经。春、秋两季采挖,除去茎叶,洗净,润透,切成厚片,晒干。具有活血祛瘀,通经止痛,清心除烦,凉血消痈的功效。用于胸痹心痛,脘腹胁痛,瘕瘕积聚,热痹疼痛,心烦不眠,月经不调,痛经经闭,疮疡肿痛。丹参提取物为棕红色的粉末,是唇形科植物丹参的干燥根及根茎提取物,含有丹参酮、隐丹参酮、异丹参酮、丹参新酮、丹参醇等生物活性物质,同时还含有维生素A、E及铁、钾等金属元素。丹参酮具有雌性激素样功能,雌性激素可使皮脂腺缩小而减少皮脂分泌。性味苦,微寒;归心、心包、肝经。具有活血调经,祛瘀止痛,凉血消痈,除烦安神的功效。主治月经不调,闭经痛经,产后瘀滞腹痛,血瘀心痛,脘腹疼痛,癥瘕积聚,跌打损伤,风湿痹证,疮痈肿毒,热病烦躁神昏,心悸失眠。
茜草为茜草科植物茜草的根和根茎。春、秋季采挖,除去泥沙,晒干。性寒,味苦。归肝经。根含多种羟基蒽醌衍生物,如茜草素、异茜草素、羟基茜草素、伪羟基茜草素、茜草酸、茜草甙、大黄素甲醚等,又分离得升白活性成分茜草萘酸甙Ⅰ及Ⅱ,其甙元为茜草萘酸。功能主治为:凉血活血,祛瘀,通经。用于吐血、衄血、崩漏下血、外伤出血、经闭瘀阻、关节痹痛、跌扑肿痛。凉血止血,活血祛瘀:本品止血而不留瘀,用于热证出血、经闭腹痛、跌打损伤。
地榆采用生地榆,为蔷薇科植物地榆或长叶地榆的干燥根。春季将发芽时或秋季植株枯萎后采挖,除去须根,洗净,干燥,或趁鲜切片,干燥。性味苦、酸、涩,微寒。归肝、大肠经。具有凉血止血,解毒敛疮的功效。用于便血,痔血,血痢,崩漏,水火烫伤,痈肿疮毒。
白茅根为禾本科植物白茅的根茎。春、秋二季采挖,除去须根及膜质叶鞘,洗净,晒干,切段生用。性味甘,寒;归肺、胃、膀胱经。具有凉血止血,清热利尿,清肺胃热的功效。主治血热出血证,水肿,热淋,黄疸,胃热呕吐,肺热咳喘。本品能显著缩短出血和凝血时间,其水煎剂和水浸剂有利尿作用,以给药5-10天时作用明显;对肺炎球菌、卡他球菌、流感杆菌、金黄色葡萄球菌及福氏、宋氏痢疾杆菌等有抑制作用,有一定抗HBV病毒能力。
芦根为单子叶植物禾本科芦苇的根茎。除去杂质及须根,洗净,稍润,切段,干燥。贮干燥容器内,置通风干燥处,防霉,防蛀。鲜芦根埋入湿沙中,防干。性味甘,寒。归肺、胃经。具有清热泻火,生津止渴,除烦,止呕,利尿的功效。用于热病烦渴,肺热燥咳,内热消渴,疮疡肿毒。
锦葵为锦葵科植物锦葵的花、叶和茎。我国南北各城市常见栽培,偶有逸生。夏、秋季采收,晒干。晒干脱粒,去杂质,放干燥阴凉处贮藏。味咸,性寒。归肺、大肠、膀胱经。具有利尿通便,清热解毒之功效。常用于大小便不畅,带下,淋巴结结核,咽喉肿痛。
蒲黄采用生蒲黄,为香蒲科植物水烛香蒲、东方香蒲或同属植物的干燥花粉。夏季采收蒲棒上部的黄色雄性花序,晒干后碾轧,筛取细粉,生用或炒用。性味甘,平;归肝、心包经。具有止血,化瘀,利尿的功效。主治出血证,瘀血痛证,血淋尿血。
焦三仙是三味药,即焦麦芽、焦山楂、焦神曲。经常合用有良好的消积化滞作用。焦麦芽有很好的消化淀粉类食物的作用;焦山楂善于治疗肉类或油腻过多所致的食滞;焦神曲则利于消化米面食物。三药合用,能明显地增强消化功能。
优选地,该组合物的原料按重量份数计包含:荆芥穗炭8~15份、防风5~7份、白芷5~7份、苏叶8~12份、苏梗8~14份、黄连1~3份、丹参8~15份、茜草8~15份、地榆8~15份、白茅根25~35份、芦根25~35份、锦葵0.5~1.5份、蒲黄5~7份,以及焦麦芽、焦山楂、焦神曲各8~12份组成的焦三仙。
更优选地,该原料按重量份数计包含:荆芥穗炭10份、防风6份、白芷6份、苏叶10份、苏梗10份、黄连2份、丹参10份、茜草10份、地榆10份、白茅根30份、芦根30份、锦葵1份、蒲黄6份,以及焦麦芽、焦山楂、焦神曲各10份组成的焦三仙。
最优选地,该原料按重量计包含:荆芥穗炭10g、防风6g、白芷6g、苏叶10g、苏梗10g、黄连2g、丹参10g、茜草10g、地榆10g、白茅根30g、芦根30g、锦葵1g、蒲黄6g,以及焦麦芽、焦山楂、焦神曲各10g组成的焦三仙。
各原料均采用野生中草药材,多年生的采用五年或以上的药材。取材自野生珍稀动植物的,在条件不允许的情况下可以采用取自人工养殖和种植的材料,或其他等效以及效果接近的替代物。
本发明还提供了该用于尿毒症和降低肌酐的组合物的用途,该组合物用于制备内服的药剂。
本发明还提供了该药剂的制备方法,该方法为:按比例称量各药物,并将可清洗的原料洗净干燥,然后将全部原料研磨破碎,再加水煎煮,得到汤剂。
所得的汤剂,每天口服一剂。
该方法中采用的其它具体条件和设备等均采用本领域技术人员所已知的。
下面结合实施例对本发明提供的用于尿毒症和降低肌酐的组合物及其用途与制备方法做更进一步描述。
实施例1
一种用于尿毒症和降低肌酐的组合物,该组合物的原料按重量计包含:荆芥穗炭10g、防风6g、白芷6g、苏叶10g、苏梗10g、黄连2g、丹参10g、茜草10g、地榆10g、白茅根30g、芦根30g、锦葵1g、蒲黄6g,以及焦麦芽、焦山楂、焦神曲各10g组成的焦三仙。
本实施例还提供了该用于尿毒症和降低肌酐的组合物的用途,该组合物用于制备内服的药剂。
本实施例还提供了该药剂的制备方法,该方法为:按比例称量各药物,并将可清洗的原料洗净干燥,然后将全部原料研磨破碎,再加水煎煮,得到汤剂。
所得的汤剂,每天口服一剂。
实施例2
一种用于尿毒症和降低肌酐的组合物,该组合物的原料按重量计包含:荆芥穗炭8g、防风5g、白芷5g、苏叶8g、苏梗8g、黄连1g、丹参8g、茜草8g、地榆8g、白茅根25g、芦根25g、锦葵0.5g、蒲黄5g,以及焦麦芽、焦山楂、焦神曲各8g组成的焦三仙。
本实施例还提供了该用于尿毒症和降低肌酐的组合物的用途,该组合物用于制备内服的药剂。
本实施例还提供了该药剂的制备方法,该方法为:按比例称量各药物,并将可清洗的原料洗净干燥,然后将全部原料研磨破碎,再加水煎煮,得到汤剂。
所得的汤剂,每天口服一剂。
实施例3
一种用于尿毒症和降低肌酐的组合物,该组合物的原料按重量计包含:荆芥穗炭15g、防风7g、白芷7g、苏叶12g、苏梗14g、黄连3g、丹参15g、茜草15g、地榆15g、白茅根35g、芦根35g、锦葵1.5g、蒲黄7g,以及焦麦芽、焦山楂、焦神曲各12g组成的焦三仙。
本实施例还提供了该用于尿毒症和降低肌酐的组合物的用途,该组合物用于制备内服的药剂。
本实施例还提供了该药剂的制备方法,该方法为:按比例称量各药物,并将可清洗的原料洗净干燥,然后将全部原料研磨破碎,再加水煎煮,得到汤剂。
所得的汤剂,每天口服一剂。
实施例4
一种用于尿毒症和降低肌酐的组合物,该组合物的原料按重量计包含:荆芥穗炭20g、防风12g、白芷12g、苏叶20g、苏梗20g、黄连4g、丹参20g、茜草20g、地榆20g、白茅根60g、芦根60g、锦葵2g、蒲黄12g,以及焦麦芽、焦山楂、焦神曲各20g组成的焦三仙。
本实施例还提供了该用于尿毒症和降低肌酐的组合物的用途,该组合物用于制备内服的药剂。
本实施例还提供了该药剂的制备方法,该方法为:按比例称量各药物,并将可清洗的原料洗净干燥,然后将全部原料研磨破碎,再加水煎煮,得到汤剂。
所得的汤剂,每天口服一剂。
本发明各实施例中采用的原料分别符合相应的国家标准。
采用本发明各实施例制备的药剂进行临床试用,结果证明该组合物有明显功效,可以有效调节人体五脏六腑,排毒利尿,降低肌酐和恢复正常肌酐值,从而达到恢复肾衰竭,乃至恢复肾脏功能的效果。
该组合物还具有组方合理、用量少、效果显著、无毒副作用、迅速起效等特点,以及成分简单易得、加工方便、价廉物美、经济实用等优点。所得的药剂又名昆仑六绝散。
本发明提供的用于尿毒症和降低肌酐的组合物及其用途与制备方法,经中医辨证,针对病证的病因病机,利用药物相辅相成的配伍原理,有目的地将诸药按君、臣、佐、使的组织结构合理配伍,使方中的药物及其配伍与病证的病机丝丝入扣,使药物配伍后的综合效用与所立治法高度统一。
尽管本发明的内容已经通过上述优选实施例作了详细介绍,但应当认识到上述的描述不应被认为是对本发明的限制。在本领域技术人员阅读了上述内容后,对于本发明的多种修改和替代都将是显而易见的。因此,本发明的保护范围应由所附的权利要求来限定。
Claims (8)
1.一种用于尿毒症和降低肌酐的组合物,其特征在于,该组合物的原料包含:荆芥穗炭、防风、白芷、苏叶、苏梗、黄连、丹参、茜草、地榆、白茅根、芦根、锦葵、蒲黄、焦三仙。
2.如权利要求1所述的用于尿毒症和降低肌酐的组合物,其特征在于,所述的组合物的原料中,焦三仙由焦麦芽、焦山楂、焦神曲按重量比1:1:1组成。
3.如权利要求1所述的用于尿毒症和降低肌酐的组合物,其特征在于,所述的组合物的原料按重量份数计包含:荆芥穗炭8~15份、防风5~7份、白芷5~7份、苏叶8~12份、苏梗8~14份、黄连1~3份、丹参8~15份、茜草8~15份、地榆8~15份、白茅根25~35份、芦根25~35份、锦葵0.5~1.5份、蒲黄5~7份,以及焦麦芽、焦山楂、焦神曲各8~12份组成的焦三仙。
4.如权利要求3所述的用于尿毒症和降低肌酐的组合物,其特征在于,所述的原料按重量份数计包含:荆芥穗炭10份、防风6份、白芷6份、苏叶10份、苏梗10份、黄连2份、丹参10份、茜草10份、地榆10份、白茅根30份、芦根30份、锦葵1份、蒲黄6份,以及焦麦芽、焦山楂、焦神曲各10份组成的焦三仙。
5.如权利要求4所述的用于尿毒症和降低肌酐的组合物,其特征在于,所述的原料按重量计包含:荆芥穗炭10g、防风6g、白芷6g、苏叶10g、苏梗10g、黄连2g、丹参10g、茜草10g、地榆10g、白茅根30g、芦根30g、锦葵1g、蒲黄6g,以及焦麦芽、焦山楂、焦神曲各10g组成的焦三仙。
6.一种如权利要求1~5中任意一项所述的用于尿毒症和降低肌酐的组合物的用途,其特征在于,所述的组合物用于制备内服的药剂。
7.一种如权利要求6所述的药剂的制备方法,其特征在于,所述的方法为:按比例称量各药物,并将可清洗的原料洗净干燥,然后将全部原料研磨破碎,再加水煎煮,得到汤剂。
8.如权利要求7所述的药剂的制备方法,其特征在于,所述的汤剂,每天口服一剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210057119.7A CN114392327A (zh) | 2022-01-19 | 2022-01-19 | 一种用于尿毒症和降低肌酐的组合物及其用途与制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210057119.7A CN114392327A (zh) | 2022-01-19 | 2022-01-19 | 一种用于尿毒症和降低肌酐的组合物及其用途与制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114392327A true CN114392327A (zh) | 2022-04-26 |
Family
ID=81231195
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210057119.7A Pending CN114392327A (zh) | 2022-01-19 | 2022-01-19 | 一种用于尿毒症和降低肌酐的组合物及其用途与制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114392327A (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101590190A (zh) * | 2008-05-26 | 2009-12-02 | 张瑞娥 | 一种治疗尿毒症的中药组合物 |
-
2022
- 2022-01-19 CN CN202210057119.7A patent/CN114392327A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101590190A (zh) * | 2008-05-26 | 2009-12-02 | 张瑞娥 | 一种治疗尿毒症的中药组合物 |
Non-Patent Citations (2)
Title |
---|
刘春丽: "尿毒症的中医辨证论治", 《中国中医药现代远程教育》 * |
赵东升: "赵绍琴教授从邪实论治肾病的经验", 《新中医》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113730479A (zh) | 一种具有保健功能的组合物及其制备方法与用途 | |
CN112675278A (zh) | 润肺止咳、抑制肺部炎症反应的组合物及其制备方法和用途 | |
CN114392327A (zh) | 一种用于尿毒症和降低肌酐的组合物及其用途与制备方法 | |
CN113440577A (zh) | 一种用于治疗糖尿病的夜服藏药及其制备方法 | |
CN102940762B (zh) | 一种治疗痛风性关节炎的中药 | |
CN111700948A (zh) | 一种预防和治疗新冠肺炎的外用中药及其制备方法 | |
CN112138096A (zh) | 用于头皮保健黑发生发的药物组合物及其制备方法与用途 | |
CN105561098A (zh) | 一种治疗糜烂性脚气的药物 | |
CN110772598A (zh) | 一种治疗口疮的组合物、其应用及服用方法 | |
CN111686165A (zh) | 私处止痒的纯中药组合物、制剂及在清洁私处中的应用 | |
CN106075283B (zh) | 一种提高阉割公鸡存活率的中药组合物、制备方法及应用 | |
CN104922648A (zh) | 一种治疗鸡腹泻的中药组合物及其制备方法 | |
CN104800440A (zh) | 一种用于治疗过敏性紫癜的中药 | |
CN110917271A (zh) | 一种用于儿童、青少年过敏性哮喘合并过敏性鼻炎防治的喷雾剂 | |
CN110917302A (zh) | 一种治疗糖尿病的中药及其制备方法 | |
CN112972621A (zh) | 一种治疗扁平疣的药物配方 | |
CN105748685B (zh) | 一种脚气抑菌剂及其制备方法 | |
CN114344434B (zh) | 一种治疗肺结节的中药组合物及其制备方法 | |
CN108714167B (zh) | 一种治疗白癜风的中药外用制剂及其制备方法 | |
CN114796316B (zh) | 一种防脱发促生发的中药组合物、制备方法和应用 | |
CN103316252A (zh) | 一种治疗肝纤维化的中药 | |
CN103585470B (zh) | 一种治疗肺炎球菌肺炎的中药 | |
CN115501295A (zh) | 一种用于润肺止咳化痰消炎的药物颗粒及其制备方法 | |
CN107334956B (zh) | 一种降血压的中药制剂及其制备方法 | |
CN113769041A (zh) | 一种用于治疗妇科炎症的外用中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220426 |
|
RJ01 | Rejection of invention patent application after publication |